Targeting Cognition in Bipolar Disorder With Pramipexole

NCT02397837 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

103

Enrollment

OTHER

Sponsor class

Conditions

Bipolar Disorder

Interventions

DRUG: Pramipexole
DRUG: Placebo

Sponsor

Brigham and Women's Hospital

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]